Carregant...

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer

A number of pharmacogenetic studies have been carried out in non-small-cell lung cancer (NSCLC) to identify and characterize genes involved in chemotherapy activity. However, the results obtained so far are controversial and no reliable biomarker is currently used to predict clinical benefit from pl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Toffalorio, Francesca, Santarpia, Mariacarmela, Radice, Davide, Jaramillo, Christopher Adrian, Spitaleri, Gianluca, Manzotti, Michela, Catania, Chiara, Jordheim, Lars Petter, Pelosi, Giuseppe, Peters, Godefridus J., Tibaldi, Carmelo, Funel, Niccola, Spaggiari, Lorenzo, de Braud, Filippo, De Pas, Tommaso, Giovannetti, Elisa
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5893252/
https://ncbi.nlm.nih.gov/pubmed/29662657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24505
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!